Primary bone cancer starts in the bone. The most common types include osteosarcoma, Ewing sarcoma, and chondrosarcoma, and each has a different treatment pathway. Osteosarcoma and Ewing sarcoma often need chemotherapy as well as treatment to the original tumour, while surgery is usually the main treatment for conventional chondrosarcoma. If a scan suggests a primary bone cancer, the bone sarcoma team should review the imaging and plan the biopsy before it is performed. [1–3]
By Dr Raman Narang, Consultant Medical & Hemato-Oncologist, New Delhi
A scan report that says “bone lesion” can raise several questions at once. Could it be a benign growth, a cancer that started in the bone, or a cancer that spread there from another organ? If you are seeking bone cancer treatment in Delhi, the first priority is to establish which of these possibilities fits the imaging and clinical findings. That determines whether a biopsy is needed, how it should be done, and which treatment should come first. [1]
1. What are the symptoms of bone cancer?
Possible symptoms include persistent pain in one area, a growing swelling or lump, reduced movement near a joint, or a limp. Pain may initially come and go and become more persistent over time. Sometimes a bone weakened by a tumour breaks after a minor injury. [1–3]
In children and young adults, pain around the knee, thigh, or shoulder may first be noticed during sport. Pain that keeps worsening, occurs at rest, or is accompanied by a growing swelling deserves assessment. In adults who have previously had cancer, persistent new bone pain should also be reviewed because it can have several causes, including bone metastases. [1–3]
Sudden severe pain with an inability to bear weight after a minor injury needs urgent assessment. New back pain with leg weakness, numbness, or a loss of bladder or bowel control needs emergency evaluation because a tumour near the spine can press on the spinal cord or nearby nerves. [1, 4]
2. What are the main types of primary bone cancer?
Bone sarcomas are classified by what the tumour cells look like, what tissue they make, and, for some subtypes, which genetic changes they carry. The subtype and grade can determine whether chemotherapy is likely to help and whether surgery or radiation should be used for local control. [1–3]
| Type | What distinguishes it |
|---|---|
| Osteosarcoma | The tumour cells make immature bone. Conventional high-grade osteosarcoma often affects adolescents and young adults and commonly starts near the knee or shoulder. It can occur at other ages and sites. |
| Ewing sarcoma | A sarcoma that often affects children, teenagers, and young adults. It can start in bone or soft tissue. Molecular testing helps distinguish it from other tumours that look similar under the microscope. |
| Chondrosarcoma | The tumour produces cartilage. It is more common in adults. The grade and subtype matter because conventional, mesenchymal, and dedifferentiated chondrosarcomas can require different approaches. |
| Chordoma | A rare tumour that typically starts at the base of the skull, in the spine, or in the sacrum. Its proximity to important nerves and other structures makes specialist surgery and radiation planning important. |
| Other bone sarcomas | Include undifferentiated pleomorphic sarcoma of bone and several rarer types. Expert pathology review can change the treatment recommendation. |
In adults, a malignant lesion in bone may also be a metastasis from a cancer that started elsewhere, such as the breast, prostate, lung, or kidney. Multiple myeloma can also cause bone lesions and follows a separate treatment pathway. [1, 4]
3. How is bone cancer diagnosed, and why does biopsy planning matter?
An X-ray is often the first test for a suspicious bone lesion. If the findings raise concern, MRI helps show how much of the bone is involved, whether the tumour extends into surrounding soft tissues, and how close it is to a joint, major blood vessel, or nerve. Staging commonly includes CT of the chest because the lungs are an important site of spread for several bone sarcomas. Additional whole-body imaging is selected according to the subtype and clinical findings. [1–3]
A core needle biopsy is often used to confirm the diagnosis. For a suspected primary bone sarcoma, the team should review the imaging before the procedure and plan the route with the surgeon who would perform the definitive operation. The path the needle takes may need to be removed with the tumour later. A well-planned biopsy can help preserve surgical options. [1]
The pathologist may use immunohistochemistry or molecular testing to confirm the exact subtype. For example, Ewing sarcoma commonly has an EWSR1::FLI1 fusion. A report showing an EWSR1 rearrangement is interpreted alongside the appearance of the cells and, where needed, the specific fusion partner, because other tumours can also show an EWSR1 rearrangement. [1, 3]
4. How is localised or locally advanced bone cancer treated?
Localised means there is no detected distant spread. A tumour can still be difficult to remove if it extends into nearby tissues or is close to critical structures. The team considers where it sits, whether it can be removed with clear margins, and what function can be preserved. [1–3]
| Diagnosis | Usual treatment approach |
|---|---|
| High-grade osteosarcoma | Chemotherapy is commonly given before and after surgery. In children and many young adults, MAP is a common regimen combining high-dose methotrexate, doxorubicin, and cisplatin. The regimen is adapted to age, organ function, and treatment tolerance. Selected low-grade osteosarcomas may be treated with surgery alone. |
| Ewing sarcoma | Treatment generally starts with combination chemotherapy, followed by surgery, radiation, or bothto control the original tumour. One commonly used regimen alternates VDC with IE. Chemotherapy continues after local treatment as part of the planned course. |
| Conventional chondrosarcoma | Surgery is usually the main treatment when the tumour can be removed. The grade and site guide how much tissue needs to be removed. Chemotherapy has a limited role in conventional chondrosarcoma. |
| Chordoma | Specialist surgery, high-dose focused radiation, or both may be considered. The approach depends on the location and the risks to nearby structures. |
When is limb-sparing surgery possible? The surgeon considers whether the tumour can be removed with an adequate margin and whether the reconstructed limb is likely to function well. The position of the tumour, involvement of nerves or blood vessels, and options for reconstruction all matter. In some situations, amputation may provide more reliable tumour removal or better expected function. Ask what each realistic option would mean for mobility, rehabilitation, and daily activities. [1, 2]
5. How are metastatic bone sarcoma and bone metastases treated?
Metastatic bone sarcoma means a cancer that started in bone has spread, for example to the lungs or other bones. Treatment depends on the subtype and the amount and location of spread. In selected patients with osteosarcoma and limited lung metastases that can all be removed, chemotherapy and surgery may still be planned with the aim of cure. In metastatic Ewing sarcoma, systemic chemotherapy remains central, with surgery or radiation considered for the original tumour and selected sites of spread. [1–3]
Bone metastases from another cancer are treated according to the cancer’s original site and biology. For example, breast cancer that spreads to bone follows the breast cancer treatment pathway. Radiation can help relieve bone pain, and orthopaedic surgery may be needed when a bone has broken or is at high risk of breaking. Bone-strengthening medicines such as zoledronic acid or denosumab may be appropriate for selected patients, depending on the cancer and individual circumstances. [4]
What I look for clinically before recommending treatment
I start with the original X-ray and MRI. If the biopsy is pending, I check whether the route has been discussed with the treating bone sarcoma surgeon. Once the pathology is available, I want to know whether the subtype calls for chemotherapy first or whether surgery is the main treatment. I also ask what needs attention now, such as pain, difficulty walking, or the risk of a fracture. Those concerns can affect what happens while the remaining tests are being arranged.
How the next step is decided
| If the reports show… | The next discussion is about… |
|---|---|
| A suspicious bone lesion without a diagnosis | Specialist imaging review and a planned biopsy |
| High-grade osteosarcoma confined to the original site | Chemotherapy, timing of surgery, and reconstruction |
| Ewing sarcoma | Systemic chemotherapy and the role of surgery, radiation, or both |
| Conventional chondrosarcoma | Whether complete removal is feasible and what surgery would involve |
| A bone sarcoma with a small number of lung metastases | Whether treatment can address both the original tumour and all known sites of spread |
| A bone lesion in someone with a previous cancer diagnosis | Whether imaging and clinical findings establish the cause or a biopsy would change treatment |
What to bring to a bone cancer consultation in Delhi
- X-rays, MRI, CT, or PET-CT reports and the original images.
- Biopsy report and details for obtaining the pathology slides or tissue block.
- Biopsy procedure notes, including where the sample was taken, if available.
- Immunohistochemistry and molecular test results, if performed.
- Records of any previous cancer, surgery, chemotherapy, or radiation.
- A note of when the pain or swelling started and how it affects walking, sleep, or daily activities.
Frequently asked questions
Does a bone lesion on an X-ray mean cancer?
Many bone lesions are benign. Age, symptoms, and the imaging appearance help determine whether further imaging, monitoring, or a biopsy is needed. [1]
Does everyone with bone cancer need chemotherapy?
Chemotherapy is an important part of treatment for high-grade osteosarcoma and Ewing sarcoma. For most conventional chondrosarcomas, surgery is the main treatment. The biopsy subtype and grade guide the decision. [1–3]
Can bone cancer be treated without amputation?
Limb-sparing surgery is possible for many patients. The decision depends on whether clear margins can be achieved and whether the limb is likely to function well after reconstruction. [1, 2]
Can stage IV bone cancer still be treated with the aim of cure?
In selected cases, yes. For example, some patients with osteosarcoma and limited, removable lung metastases may be treated with that goal. The subtype, sites of spread, and feasibility of treating all known disease matter. [1–3]
Before treatment, ask for the exact subtype, the extent of disease, and the reason for choosing chemotherapy, surgery, or radiation first. If an operation is planned, ask what the surgeon expects to remove, what can be preserved, and what rehabilitation may involve.
This page is for general education. Individual treatment decisions require review of your imaging, pathology, symptoms, and overall health by your treating team.
Clinical references
- British Sarcoma Group. UK Guidelines for the Management of Bone Sarcomas. British Journal of Cancer, 2025.
- National Cancer Institute. Osteosarcoma and Undifferentiated Pleomorphic Sarcoma of Bone Treatment (PDQ).Health Professional Version.
- National Cancer Institute. Ewing Sarcoma Treatment (PDQ). Health Professional Version.
- National Cancer Institute. Metastatic Cancer: When Cancer Spreads. See also British Sarcoma Group guidance for assessment of suspected primary bone tumours.